Press MF - Search Results

1

Early Detection of Ovarian Cancer Using Cell-Free DNA Fragmentomes and Protein Biomarkers.

Medina JE, Annapragada AV, Lof P, Short S, Bartolomucci AL, Mathios D, Koul S, Niknafs N, Noë M, Foda ZH, Bruhm DC, Hruban C, Vulpescu NA, Jung E, Dua R, Canzoniero JV, Cristiano S, Adleff V, Symecko H, van den Broek D, Sokoll LJ, Baylin SB, Press MF, Slamon DJ, Konecny GE, Therkildsen C, Carvalho B, Meijer GA, Andersen CL, Domchek SM, Drapkin R, Scharpf RB, Phallen J, Lok CAR, Velculescu VE. Medina JE, et al. Among authors: press mf. Cancer Discov. 2025 Jan 13;15(1):105-118. doi: 10.1158/2159-8290.CD-24-0393. Cancer Discov. 2025. PMID: 39345137 Free PMC article.

2

Expression of the HER-2/neu proto-oncogene in normal human adult and fetal tissues.

Press MF, Cordon-Cardo C, Slamon DJ. Press MF, et al. Oncogene. 1990 Jul;5(7):953-62. Oncogene. 1990. PMID: 1973830

3

HER-2/neu oncogene amplification and expression in breast and ovarian cancers.

Press MF, Jones LA, Godolphin W, Edwards CL, Slamon DJ. Press MF, et al. Prog Clin Biol Res. 1990;354A:209-21. Prog Clin Biol Res. 1990. PMID: 1978943 Review. No abstract available.

4

Subnuclear localization of the trans-activating protein of human T-cell leukemia virus type I.

Slamon DJ, Boyle WJ, Keith DE, Press MF, Golde DW, Souza LM. Slamon DJ, et al. Among authors: press mf. J Virol. 1988 Mar;62(3):680-6. doi: 10.1128/JVI.62.3.680-686.1988. J Virol. 1988. PMID: 2828664 Free PMC article.

5

Expression patterns of immediate early transcription factors in human non-small cell lung cancer. The Lung Cancer Study Group.

Levin WJ, Press MF, Gaynor RB, Sukhatme VP, Boone TC, Reissmann PT, Figlin RA, Holmes EC, Souza LM, Slamon DJ. Levin WJ, et al. Among authors: press mf. Oncogene. 1995 Oct 5;11(7):1261-9. Oncogene. 1995. PMID: 7478546

6

Amplification and overexpression of HER-2/neu in carcinomas of the salivary gland: correlation with poor prognosis.

Press MF, Pike MC, Hung G, Zhou JY, Ma Y, George J, Dietz-Band J, James W, Slamon DJ, Batsakis JG, et al. Press MF, et al. Cancer Res. 1994 Nov 1;54(21):5675-82. Cancer Res. 1994. PMID: 7522962

7

Sensitivity of HER-2/neu antibodies in archival tissue samples: potential source of error in immunohistochemical studies of oncogene expression.

Press MF, Hung G, Godolphin W, Slamon DJ. Press MF, et al. Cancer Res. 1994 May 15;54(10):2771-7. Cancer Res. 1994. PMID: 7909495

8

Detection and quantitation of HER-2/neu gene amplification in human breast cancer archival material using fluorescence in situ hybridization.

Pauletti G, Godolphin W, Press MF, Slamon DJ. Pauletti G, et al. Among authors: press mf. Oncogene. 1996 Jul 4;13(1):63-72. Oncogene. 1996. PMID: 8700555

9

Evaluation of HER-2/neu gene amplification and overexpression: comparison of frequently used assay methods in a molecularly characterized cohort of breast cancer specimens.

Press MF, Slamon DJ, Flom KJ, Park J, Zhou JY, Bernstein L. Press MF, et al. J Clin Oncol. 2002 Jul 15;20(14):3095-105. doi: 10.1200/JCO.2002.09.094. J Clin Oncol. 2002. PMID: 12118023

10

Results of two open-label, multicenter phase II studies of docetaxel, platinum salts, and trastuzumab in HER2-positive advanced breast cancer.

Pegram MD, Pienkowski T, Northfelt DW, Eiermann W, Patel R, Fumoleau P, Quan E, Crown J, Toppmeyer D, Smylie M, Riva A, Blitz S, Press MF, Reese D, Lindsay MA, Slamon DJ. Pegram MD, et al. Among authors: press mf. J Natl Cancer Inst. 2004 May 19;96(10):759-69. doi: 10.1093/jnci/djh133. J Natl Cancer Inst. 2004. PMID: 15150304 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

231 results

Search Page

Filters